GLENMARK 
Glenmark Pharmaceuticals Ltd
How do you think glenmark will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 76
71 outperforms
5 underperforms
Stars: Top Investors who have picked this stock: 9
8 outperforms
1 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 532296 / GLENMARK
- Last traded time
- 2012-02-23 11:59:45
- Last traded on
- NSE
- Intra-day Low / High
- 303.2 / 309.9
- 52w closing Low / High
- 251.3 / 342.3
- Today Volume
- 61,014
- 30d avg Daily Volume
- 840,366
- Market Cap
- INR 8,320.6 cr
- P/E Ratio TTM
- 45.50
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -1.4%
- -0.2%
- -2.4%
- -2.4%
- 7.1%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks
Top 10% Members' PicksAll Members' Picks
Active Picks OnlyClosed Picks OnlyAll Picks
| Member | Member Rating | Start Date | Call | Horizon | Start Price | Dividend Value | Stock Returns (A) | Index Returns (B) | Net points (A)-(B) | Comment |
|---|---|---|---|---|---|---|---|---|---|---|
| IntuitTrade | 99.6 | 13-Feb-12 |  |
1w | 302.05 | 0.00 | 0.81% | 2.02% | -1.21 | |
| rakshit | 98.4 | 13-Jul-11 | |
3m | 317.90 | 0.40 | -4.09% | -1.40% | -2.69 | |
| prverma | 92.9 | 24-Aug-09 |  |
1y | 212.30 | 1.20 | -43.99% | -18.01% | -25.98 | |
| parminder | 95.8 | 13-Aug-09 | |
6m | 256.00 | 1.20 | 19.41% | 20.54% | -1.13 | |
| jiinu | 98.5 | 26-Jun-09 | |
6m | 231.95 | 1.20 | 31.80% | 28.28% | 3.52 | |
| HIM02ME1038 | 92.4 | 09-Jun-09 | |
6m | 218.45 | 1.20 | 39.94% | 21.41% | 18.53 | |
| shridharnse | 91.6 | 02-Mar-09 | |
6m | 143.70 | 1.20 | 112.73% | 102.99% | 9.74 | |
It is time people got into this for a safe upward ride. Reply | ||||||||||
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
GLENMARK IN THE NEWS
- Feb-14 16:58 Glenmark Pharmaceuticals allots shares
- Feb-14 11:28 Glenmark's novel molecule 'GRC 17536' successfully completes Phase I trials in Europe
- Jan-30 17:16 Glenmark Pharmaceuticals net profit declines 77.33% in the December 2011 quarter
- Jan-30 16:45 Glenmark Pharmaceuticals appoints additional directors
- Jan-21 8:01 Glenmark Generics receives two oral contraceptives product approvals
- Jan-21 8:01 Glenmark Pharmaceuticals to announce Q3 results
- Dec-28 14:43 Glenmark Pharmaceuticals receives DCGI (India) approval
- Dec-09 17:25 Glenmark Pharmaceuticals issues stock options
- Nov-28 15:39 Glenmark Generics gets tentative approval for Montelukast Sodium 10 mg tablets
- Nov-10 8:09 Glenmark Pharmaceuticals appoints director
TOP BLOGS
- Advice for – Thursday, February 23, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Navbharat Ventures, Dr Reddys, Godrej properties and Bombay Burmah Investment Pick!
by NOORESH MERANI
(Recommendations: 9) - Market outlook for rest of the week
by ASHOKSHARMA
(Recommendations: 8) - Buy the Dips
by Nishit_Vadhavkar
(Recommendations: 7) - Advice for – Tuesday, February 14, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Raising portfolio quality
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 7) - How does owning spectrum help us?
by Ray_Titus
(Recommendations: 7) - Liquidity drives the market
by Nishit_Vadhavkar
(Recommendations: 7) - Sensex- Technical Outlook and Trading Levels, 3 February 2012
by D_Sathiamoorthy
(Recommendations: 7) - SENSEX and NIFTY -- Setting up for a False Breakout – Be Cautious
by NOORESH MERANI
(Recommendations: 9)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |